Home
||
Export Import Policy & DGFT matters
|| Customs
matters || Central Excise matters ||
Shipping and Logistics Information
ieport.com - India's
Premier portal on EXIM matters
Notification
No-02/2005-CE(N.T.) Dated 7.1.2005
Medicaments now
subjected to excise on MRP basis with effect from
January 8; Abatement of 35 % allowed
In exercise of the powers conferred by sub-section (1) and sub-section (2) of
section 4A of the Central Excise Act, 1944 (1 of 1944), the Central Government
hereby specifies the goods mentioned in column (3) of the Table below and
falling under Chapter or Heading No. or Sub-heading No. of the First Schedule to
the Central Excise Tariff Act, 1985 (5 of 1986) mentioned in the corresponding
entry in column (2) of the said Table, as the goods to which the provisions of
the said sub-section (2) shall apply, and allows as abatement the percentage of
retail sale price mentioned in the corresponding entry in column (4) of the said
| S. No. | Chapter or Heading No. or Sub-heading No. | Description | Abatement as a percentage of retail sale price |
|---|---|---|---|
| (1) | (2) | (3) | (4) |
| 1. | 3003.10 | Patent or proprietary medicaments, other than those medicaments which are exclusively Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic | 35% |
| 2. | 3003.20 | Medicaments (other than patent or proprietary) other than those which are exclusively used in Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems | 35% |
2. This notification shall come into force on the 8th day of January, 2005.
Explanation - For the purposes of this notification, “ retail sale price” means
the retail price displayed by the manufacturer under the provisions of the Drugs
(Prices Control) Order, 1995.
(F.No.354/100/2004-TRU)
V.Sivasubramanian
Deputy Secretary to the Government of India